BURACCHI, CHIARA
 Distribuzione geografica
Continente #
NA - Nord America 2.578
AS - Asia 1.945
EU - Europa 1.373
SA - Sud America 324
Continente sconosciuto - Info sul continente non disponibili 118
AF - Africa 56
OC - Oceania 6
Totale 6.400
Nazione #
US - Stati Uniti d'America 2.439
SG - Singapore 711
IT - Italia 490
CN - Cina 339
HK - Hong Kong 271
BR - Brasile 238
VN - Vietnam 215
RU - Federazione Russa 199
DE - Germania 138
IE - Irlanda 116
CA - Canada 107
BD - Bangladesh 101
SE - Svezia 100
IN - India 67
FR - Francia 66
GB - Regno Unito 63
FI - Finlandia 40
AR - Argentina 34
ES - Italia 34
ID - Indonesia 33
NL - Olanda 28
KR - Corea 26
PH - Filippine 24
TR - Turchia 24
SA - Arabia Saudita 23
IQ - Iraq 22
JP - Giappone 19
UA - Ucraina 19
ZA - Sudafrica 19
PK - Pakistan 17
CH - Svizzera 16
MX - Messico 14
PL - Polonia 14
AT - Austria 11
EC - Ecuador 10
VE - Venezuela 10
CO - Colombia 9
CL - Cile 8
ET - Etiopia 8
IL - Israele 7
PE - Perù 7
CR - Costa Rica 6
MA - Marocco 6
MY - Malesia 6
AU - Australia 5
BE - Belgio 5
CZ - Repubblica Ceca 5
GR - Grecia 5
JO - Giordania 5
KE - Kenya 5
PY - Paraguay 5
RS - Serbia 5
UZ - Uzbekistan 5
AL - Albania 4
LT - Lituania 4
OM - Oman 4
PA - Panama 4
SK - Slovacchia (Repubblica Slovacca) 4
AE - Emirati Arabi Uniti 3
LA - Repubblica Popolare Democratica del Laos 3
LK - Sri Lanka 3
NO - Norvegia 3
NP - Nepal 3
TN - Tunisia 3
AO - Angola 2
AZ - Azerbaigian 2
BB - Barbados 2
BG - Bulgaria 2
BH - Bahrain 2
EG - Egitto 2
JM - Giamaica 2
KG - Kirghizistan 2
MU - Mauritius 2
SN - Senegal 2
UY - Uruguay 2
BF - Burkina Faso 1
CG - Congo 1
CI - Costa d'Avorio 1
CY - Cipro 1
DO - Repubblica Dominicana 1
DZ - Algeria 1
GE - Georgia 1
HN - Honduras 1
HU - Ungheria 1
KW - Kuwait 1
KZ - Kazakistan 1
LB - Libano 1
MZ - Mozambico 1
NG - Nigeria 1
NI - Nicaragua 1
NZ - Nuova Zelanda 1
PS - Palestinian Territory 1
RO - Romania 1
SC - Seychelles 1
SR - Suriname 1
SV - El Salvador 1
SY - Repubblica araba siriana 1
TW - Taiwan 1
XK - ???statistics.table.value.countryCode.XK??? 1
Totale 6.283
Città #
Singapore 404
Ann Arbor 397
Ashburn 289
Hong Kong 264
San Jose 209
Milan 131
Dublin 112
New York 101
Chandler 75
Los Angeles 68
Frankfurt am Main 66
Hefei 64
Chicago 61
Toronto 61
Fairfield 59
Santa Clara 59
Beijing 57
Ho Chi Minh City 57
Dallas 55
Hanoi 50
Rome 38
The Dalles 35
Wilmington 35
Woodbridge 31
Lauterbourg 30
Buffalo 29
Seattle 29
Houston 27
Seoul 25
Munich 24
Shanghai 23
Helsinki 22
Council Bluffs 21
Lissone 21
Princeton 21
Boardman 19
Denver 19
Orem 19
Montreal 18
Moscow 18
Jakarta 17
São Paulo 17
Cambridge 16
Tokyo 16
London 15
Pune 15
Amsterdam 14
Atlanta 14
Brooklyn 14
Nuremberg 14
San Francisco 14
Warsaw 14
Zurich 14
Johannesburg 13
Da Nang 12
Dhaka 12
Turku 12
Belo Horizonte 11
Florence 11
Fremont 10
Haiphong 10
Lawrence 10
Stockholm 10
Genoa 9
Addis Ababa 8
Altamura 8
Dong Ket 8
Jeddah 8
Poplar 8
Rio de Janeiro 8
Turin 8
Chennai 7
Desio 7
Guangzhou 7
Riyadh 7
Ankara 6
Baghdad 6
Brescia 6
City of London 6
Curitiba 6
Dammam 6
Istanbul 6
Lappeenranta 6
Biên Hòa 5
Boston 5
Brussels 5
Charlotte 5
Dearborn 5
Düsseldorf 5
Garbagnate Milanese 5
Kent 5
Kyiv 5
Lima 5
Mumbai 5
Nairobi 5
Phoenix 5
San José 5
Vienna 5
Barnet 4
Beauharnois 4
Totale 3.672
Nome #
Sleeping Beauty-engineered CAR T cells achieve anti-leukemic activity without severe toxicities 460
Targeting CD33 in Chemoresistant AML Patient-Derived Xenografts by CAR-CIK Cells Modified with an Improved SB Transposon System 431
SRC/ABL inhibition disrupts CRLF2-driven signaling to induce cell death in B-cell acute lymphoblastic leukemia 313
Monocyte–macrophage polarization and recruitment pathways in the tumour microenvironment of B-cell acute lymphoblastic leukaemia 299
Flow cytometry for minimal residual disease testing in acute leukemia: opportunities and challenges 293
Donor-derived CARCIK-CD19 cells engineered with Sleeping Beauty transposon in acute lymphoblastic leukemia relapsed after allogeneic transplantation 292
Single-cell profiling of pediatric T-cell acute lymphoblastic leukemia: Impact of PTEN exon 7 mutation on PI3K/Akt and JAK–STAT signaling pathways 282
Carcik-CD19 Cells Expand In Vivo Toward a CD8+ Memory Phenotype and Their Persistence Is Associated with a Longer Duration of Response 242
Differential expression of CD73, CD86 and CD304 in normal vs. leukemic B-cell precursors and their utility as stable minimal residual disease markers in childhood B-cell precursor acute lymphoblastic leukemia 241
Therapeutic afucosylated monoclonal antibody and bispecific T-cell engagers for T-cell acute lymphoblastic leukemia 231
Phenotypic profiling of CD34+ cells by advanced flow cytometry improves diagnosis of Juvenile Myelomonocytic Leukemia 230
Long-Term Host Immune Modulation Following Tisagenlecleucel Administration in Patients with Diffuse Large B-Cell Lymphoma and B-Lineage Acute Lymphoblastic Leukemia 208
Flow cytometric minimal residual disease assessment in B-cell precursor acute lymphoblastic leukaemia patients treated with CD19-targeted therapies — a EuroFlow study 196
Deep immunophenotypic characterization of CARCIK-CD19 pre-infusion cellular product by advanced multiparametric flow cytometry 186
Diverse mechanisms of leukemogenesis associated with PAX5 germline mutation 184
Targeted gene correction in osteopetrotic-induced pluripotent stem cells for the generation of functional osteoclasts 181
Bone Marrow Stromal Cell Regeneration Profile in Treated B-Cell Precursor Acute Lymphoblastic Leukemia Patients: Association with MRD Status and Patient Outcome 169
Acquisition of an immunosuppressive microenvironment after anti-CD19 CAR T-cell therapy is associated with T-cell dysfunction and resistance 169
Chimeric antigen receptor therapy for hematological malignancies: a pediatric perspective from leukapheresis to infusion 167
Impact of Pre-Analytical and Analytical Variables Associated with Sample Preparation on Flow Cytometric Stainings Obtained with EuroFlow Panels 152
Impact of ATLG on CD4+ T-cell reconstitution after HSCT in children: a detailed immune profiling study 149
Intestinal inflammation in mice deficient in Tir8, an inhibitory member of the IL-1 receptor family 145
Minimal residual disease assessment in B-cell precursor acute lymphoblastic leukemia by semi-automated identification of normal hematopoietic cells: A EuroFlow study 132
Automated identification of leukocyte subsets improves standardization of database-guided expert-supervised diagnostic orientation in acute leukemia: a EuroFlow study 121
Standardized flow cytometry for highly sensitive MRD measurements in B-cell acute lymphoblastic leukemia 114
Automated database-guided expert-supervised orientation for immunophenotypic diagnosis and classification of acute leukemia 112
Megakaryocytes contribute to the bone marrow-matrix environment by expressing fibronectin, type IV collagen, and laminin 110
The atypical chemokine receptor ACKR2 drives pulmonary fibrosis by tuning influx of CCR2+ and CCR5+ IFNγ-producing γδT cells in mice 103
Differential effects of immunosuppressive drugs on chemokine receptor CCR7 in human monocyte-derived dendritic cells: Selective upregulation by rapamycin 94
Increased inflammation in mice deficient for the chemokine decoy receptor D6 93
Functional TRAIL receptors in monocytes and tumor-associated macrophages: A possible targeting pathway in the tumor microenvironment 89
Control of murine Ly6Chigh monocyte traffic and immunosuppressive activities by atypical chemokine receptor D6 81
Minimal residual disease assessment following CD19-targeted therapy in B-cell precursor acute lymphoblastic leukemia using standardized 12-color flow cytometry: A EuroFlow study 79
TNF-α and the IFN-γ-inducible protein 10 (IP-10/CXCL-10) delivered by parvoviral vectors act in synergy to induce antitumor effects in mouse glioblastoma 52
Totale 6.400
Categoria #
all - tutte 22.956
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 22.956


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022226 0 39 31 19 17 23 5 10 24 19 17 22
2022/2023373 31 82 34 22 4 36 14 79 37 2 21 11
2023/2024438 13 8 17 45 55 109 91 10 25 14 4 47
2024/20251.103 45 122 44 55 101 32 58 17 109 168 117 235
2025/20263.506 430 182 228 424 435 178 468 160 280 297 141 283
2026/2027133 123 10 0 0 0 0 0 0 0 0 0 0
Totale 6.400